FGFR2/3 mutation or fusion (urothelial)
Gene: FGFR3 · Type: mutation
Indications: Bladder cancer
Linked CIViC Profile: FGFR3 MUTATION
Evidence Level Distribution
Level A: 1Level B: 2
| Level | Type | Direction | Significance | Disease | Drugs | Rating |
|---|---|---|---|---|---|---|
| A | Predictive | Supports | Sensitivity/Response | Transitional Cell Carcinoma | Erdafitinib | 4 |
| B | Predictive | Supports | Sensitivity/Response | Bladder Carcinoma | Infigratinib | 3 |
| B | Predictive | Supports | Sensitivity/Response | Urinary Bladder Cancer | Cisplatin,Gemcitabine | 3 |